Every round on record, with the sources behind each and the investors on them.
1 source · checked 1 time, last 30m ago
Developing: it holds up against its sources so far, and firms up as more reporting lands.
The source gives no amount, valuation, additional investors, or city-level headquarters.; not on the page it cites, so not applied: date
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Pre-seed pre-seed funding round | n/a | 2026-11-05 | SFC Capital | 1 outlet. #74 in Trending |
1 source · checked 1 time, last 30m ago [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 1 source The source gives no amount, valuation, additional investors, or city-level headquarters.; not on the page it cites, so not applied: date | ||||
Nayara builds clinical-grade AI companions for hospitals, health systems, and medical-technology companies that guide patients between appointments and flag issues for care teams.
Only around 10% of healthcare takes place in hospital, leaving patients to navigate questions and anxiety while clinical teams handle routine enquiries with limited visibility into progress; Nayara's agents provide guidance, emotional support, and escalation between visits. The £387,865 pre-seed led by SFC Capital is funding product development, clinical validation, and commercial expansion for a platform that the coverage says has already supported hundreds of oncology patients.
Checked against 9 sources today